Editorial Comment on: Tamoxifen as Prophylaxis for Prevention of Gynaecomastia and Breast Pain Associated with Bicalutamide 150mg Monotherapy in Patients with Prostate Cancer: A Randomised, Placebo-Controlled, Dose–Response Study-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

Editorial Comment on: Tamoxifen as Prophylaxis for Prevention of Gynaecomastia and Breast Pain Associated with Bicalutamide 150mg Monotherapy in Patients with Prostate Cancer: A Randomised, Placebo-Controlled, Dose–Response Study

Published:2007-07 Issue:1 Volume:52 Page:115
ISSN:0302-2838
Container-title:European Urology
language:en
Short-container-title:European Urology

Author:

Van Poppel Hein

Publisher

Elsevier BV

Subject

Urology

Reference4 articles.

1. Tamoxifen as prophylaxis for prevention of gynaecomastia and breast pain associated with bicalutamide 150mg monotherapy in patients with prostate cancer: a randomised, placebo-controlled, dose-response study;Fradet;Eur Urol,2007

2. Prophylactic breast irradiation with a single dose of electron beam radiotherapy (10Gy) significantly reduces the incidence of bicalutamide-induced gynaecomastia;Tyrrell;Int J Radiat Oncol Biol Phys,2004

3. Efficacy and tolerability of radiotherapy as treatment for bicalutamide-induced gynaecomastia and breast pain in prostate cancer;Van Poppel;Eur Urol,2005

4. Development and validation of a new questionnaire to assess gynaecomastia and breast pain in patients receiving bicalutamide;Van Poppel;Eur Urol Suppl,2005

Cited by 7 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Multimodality Treatment of Gynecomastia in Patients Receiving Antiandrogen Therapy for Prostate Cancer in the Era of Abiraterone Acetate and New Antiandrogen Molecules;Oncology;2013

2. Tamoxifen for the management of breast events induced by non-steroidal antiandrogens in patients with prostate cancer: a systematic review;BMC Medicine;2012-08-28

3. Androgen receptor and heterogeneous nuclear ribonucleoprotein K colocalize in the nucleoplasm and are modulated by bicalutamide and 4-hydroxy-tamoxifen in prostatic cancer cell lines;The Prostate;2011-02-14

4. An Open, Randomised, Multicentre, Phase 3 Trial Comparing the Efficacy of Two Tamoxifen Schedules in Preventing Gynaecomastia Induced by Bicalutamide Monotherapy in Prostate Cancer Patients;European Urology;2010-02

5. Gynecomastia;Endocrinology;2010

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号京ICP备18003416号-3